Prkra Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Prkra Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
PRKRA (Protein Activator of Interferon Induced Protein Kinase), also known as PACT, is a key regulator of cellular stress responses, stress granule assembly, and antiviral immunity. [2]
| Property | Value | [3]
|----------|-------| [4]
| Protein Name | Protein Activator of PKR (PACT) |
| Gene | PRKRA |
| UniProt ID | Q9UBU2 |
| PDB Structures | 4OVU, 6A5L |
| Molecular Weight | 34.6 kDa |
| Subcellular Localization | Cytoplasmic and nuclear |
| Protein Family | dsRNA-binding protein family |
| Approach | Target | Status |
|---|---|---|
| Small molecule inhibitors | Stress granule assembly | Preclinical |
| siRNA knockdown | Specific stress granule proteins | Research |
| Gene therapy | Restore normal PACT function | Research |
Prkra Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Prkra Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.